To Assess the Efficacy of Esomeprazole 40 mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole
Clinical trial NCT01249651 · COMPLETED
Trial details
- NCT number
- NCT01249651
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2011-06-01
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.